Financial statements Wörwag Pharma Operations

Cash flow statement of Wörwag Pharma Operations

Company age:
Age:
3 y. 10 m. 15 d.
Share capital:
Share capital:
5 552 300 PLN

Cash inflows of WÖRWAG PHARMA OPERATIONS

Year
2021
2022
2023
Net cash from operating expenses -15 379 635,00 -15 497 894,38 4 788 487,98
Net cash flow from investing activities -6 093 057,00 -28 535 989,40 -29 078 750,35
Net cash flow from financial activities 24 968 335,00 43 522 641,01 25 557 158,10
Total net cash flow 3 495 643,00 -511 242,77 1 266 895,73
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.